Program Leadership

Photo of Nitin Trivedi, MD, FACP

Nitin Trivedi, MD, FACP

Associate Program Director

Dr. Nitin Trivedi is an Associate Professor of Medicine at the University of Massachusetts Medical School and one of the Associate Program Directors in the Internal Medicine Residency Program at Saint Vincent Hospital in Worcester, MA. He is board certified in Internal Medicine and Endocrinology. He is a fellow of American College of Physicians and American Association of Clinical Endocrinologists. He has served as the President of the New England Chapter of American Association of Clinical Endocrinologists. He has received the Gilbert E. Levinson Award for the best resident voted by the faculty members and the John J McKeever Medical Educator Award from the Department of Medicine at Saint Vincent Hospital. His research interests include management of diabetes in hospitalized patients and insulin pump use in type 2 diabetes.

Dr. Trivedi earned his medical degrees from MGM Medical College in Indore, India and completed his Internal Medicine residency at Saint Vincent Hospital and Endocrinology fellowship at Brown Medical School. He has worked as a Research Fellow in the section of Islet Transplantation and Cell Biology at Joslin Diabetes Center, Harvard Medical School in Boston. He was an Assistant Professor at Brown Medical School from 2004 -2005.

He has authored several publications and abstracts.

Selected Bibliography:

  1. Chhabra L, Liti B, Kuraganti G, Kaul S, Trivedi N. Challenges in the management of Type 2 Diabetes Mellitus and Cardiovascular Risk Factors in Obese Subjects: What is the Evidence and What are the Myths? Int J Endocrinol Endocrinology 2013; Article ID 856793: 10 pages.
  2. Alang N, Trivedi N. Secure email communication between patients and physicians is associated with better glycemic control. R I Med J (2013). 2014 Jan 3;97(1):15.
  3. Sahni P, Trivedi A, Omer AO, Trivedi N. Adrenal incidentalomas: Are they getting work up appropriately? J Community Hospital Perspective 2016;6(5):32913. Doi:10.3402/jchimp.v6.32913.
  4. Piranavan P, Li Y, Brown E, Kemp EH, Trivedi N. Immune check point inhibitor induced hypoparathyroidism associated with calcium-sensing receptor-acting autoantibodies. J Clin Endocrinol Metab. 2018 Sep 24. doi: 10.1210/jc.2018-01151
  5. Singh P, Pandey D, Trivedi N: Insulin pump in difficult to control patients with type 2 diabetes: A single center 5 years’ experience. Cureus. 2018 Aug 31;10(8):e3240. doi: 10.7759/cureus.3240
  6. Lal A, Kaur N, Trivedi N: Metformin arterial contrast and kidney injury. Acta Biomed 2019 May 23; 90 (2): 355-356. PMID 31125020
  7. Thapa AA, Lal A, Omer A, Trivedi N: Elevated beta-hydroxybutyric acid with no ketoacidosis in type 2 diabetic patients using SGLT2 inhibitors. J Formos Med Assoc 2019 October;188 (10):1473-1474. PMID 31101495
  8. Li Mu, Gu S, Ning Y, Trivedi N, Siddique DA, Li, Huo L. County median income as an independent prognostic factor for stage IV anaplastic thyroid cancer. Anticancer Res 2019 Feb;39(2):949-956. PMID 30711980.
  9. Li M, Trived N, Dai C, Mao R, Wang Y, Ning Y, Gu SZ, Huo L, Siddique DA. Does T stage affect prognosis in patients with Stage IVB differentiated thyroid cancer? Endocr Pract 2019 Sep;25 (9): 877-886. PMID 31170365.
  10. Zhiheng H. He, Yan Li, MD, Trivedi N, Sabrina Gill, & James V. Hennessey: Thyrotoxicosis after Massive Triiodothyronine (LT3) Overdose: A Coast to Coast and 3 International Problem. Drugs in Concept 2019
  11. Upadhyay J, Trivedi N and Lal A:Risk for future diabetes in patients developing steroid-induced hyperglycemia during hospitalization for COPD exacerbation. Lung 2020, April 28th
  12. Suzuki K, Bonner-Weir, Trivedi N, Yoon KH, Lock JH, Colton CK, Weir GC: Survival and function of macroencapsulated syngeneric islets transplanted into Streptozotocin diabetic mice.Transplantation1998;66:21-28.
  13. Trivedi N, Mithal A, Sharma AK, Mishra SK, Trivedi B, Daughaday WH. Nonislet tumor induced hypoglycemia with acromegaloid facial and acral swelling. Clinical Endocrinology (Oxf.) 1995;42:433-435.
  14. Trivedi N, Suzuki K, Bonner-Weir S, Hollister-Lock J, Weir GC: Islet number in an immunobarrier required to cure diabetes in mice. Transplantation Proceedings 1997;29-21-2143.
  15. Trivedi N, Steil GM, Colton CK, Bonner Weir S, Weir GC: Improved vascularization on planar diffusion devices following continuous infusion of vascular endothelial growth factor. Cell Transplantation 1999;8:673-689.
  16. Steil GM, Trivedi N, Jonas JC, Hasenkemp WM, Sharma A, Bonner Weir, Weir GC.Enhanced beta-cell function with normal islet gene expression following Adaptation of B-cell mass to substrate oversupply. Am J Physiology 2001;280:E788-E796.
  17. Trivedi N, Keegan M, Steil GM, Hollister-Lock J, Hasenkemp WM, Colton CK, Bonner-Weir S, Weir GC. Islets in alginate macrobeads reverse diabetes despite minimal acute insulin secretory responses. Transplantation 2001;27:203-211.
  18. Omer A, Duvivier-Kaul, Trivedi N, Wilmot K, Bonner-Weir S, Weir GC. Survival and maturation of microencapsulated porcine neonatal pancreatic cell clusters transplanted into immunocompetent diabetic mice. Diabetes 2003;52(1):69-75
  19. Xu G, Kaneto H, Laybutt DR, Duvivier VF, Trivedi N, Suzuma K, Kiong GL, Weir GC, Bonner-Weir S.Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: Possible contribution to impaired incretin effect in diabetes. Diabetes 2007;56(6):1551-8.
  20. Vyas A, Fillipon N. Lynn, Vyas P, Vijayakrishnan R, Trivedi N. Successful treatment of thyroid storm in a patient with methimazole-induced toxicity.Endocrine Practice 2010;16673-675.
  21. Chhabra L, Liti B, Kuraganti G, Kaul S, Trivedi N. Challenges in the management of Type 2 Diabetes Mellitus and Cardiovascular Risk Factors in Obese Subjects: What is the Evidence and What are the Myths? Int J Endocrinol Endocrinology 2013; Article ID 856793: 10 pages.
  22. Alang N, Trivedi N. Secure email communication between patients and physicians is associated with better glycemic control.R I Med J (2013). 2014 Jan 3;97(1):15.
  23. Sahni P, Trivedi A, Omer AO, Trivedi N. Adrenal incidentaloma: Are they getting work up appropriately? J Community Hospital Perspective 2016;6(5):32913. Doi:10.3402/jchimp.v6.32913.
  24. Piranavan P, Li Y, Brown E, Kemp EH, Trivedi N. Immune check point inhibitor induced hypoparathyroidism associated with calcium-sensing receptor-acting autoantibodies. J Clin Endocrinol Metab. 2018 Sep 24. doi: 10.1210/jc.2018-01151
  25. Singh P, Pandey D, Trivedi N: Insulin pump in difficult to control patients with type 2 diabetes: A single center 5 years’ experience.Cureus 2018 Aug 31;10(8):e3240. doi: 10.7759/cureus.3240
  26. Lal A, Kaur N, Trivedi N: Metformin arterial contrast and kidney injury. Acta Biomed 2019 May 23; 90 (2): 355-356. PMID 31125020
  27. Thapa AA, Lal A, Omer A, Trivedi N: Elevated beta-hydroxybutyric acid with no ketoacidosis in type 2 diabetic patients using SGLT2 inhibitors. J Formos Med Assoc 2019 October;188 (10):1473-1474. PMID 31101495
  28. Li Mu, Gu S, Ning Y, Trivedi N, Siddique DA, Li, Huo L. County median income as an independent prognostic factor for stage IV anaplastic thyroid cancer. Anticancer Res 2019 Feb;39(2):949-956. PMID 30711980.
  29. Li M, Trived N, Dai C, Mao R, Wang Y, Ning Y, Gu SZ, Huo L, Siddique DA. Does T stage affect prognosis in patients with Stage IVB differentiated thyroid cancer? Endocr Pract 2019 Sep;25 (9): 877-886. PMID 31170365.
  30. Zhiheng H. He, Yan Li, MD, Trivedi N, Sabrina Gill, & James V. Hennessey: Thyrotoxicosis after Massive Triiodothyronine (LT3) Overdose: A Coast to Coast and 3 International Problem. Drugs Context. 2020 Jan 15;9:2019-8-4. doi: 10.7573/dic.2019-8-4. eCollection 2020
  31. Upadhyay J, Trivedi N and Lal A:Risk for future diabetes in patients developing steroid-induced hyperglycemia during hospitalization for COPD exacerbation. Lung. 2020 Jun;198(3):525-533.
  32. Nalluru, Piranavan P, Ning Y, Ackula H, Siddique A and Trivedi N: Hypocalcemia with immune checkpoint inhibitors: the disparity among various reports. Int J Endocrinology 2020 Jun 6;2020:7459268.
  33. Lal A , Haque N, Lee Jennifer , Katta SR, Maranda L , George SV, Trivedi N: Optimal Blood Glucose Monitoring Interval for Insulin Infusion in Critically Ill Non-Cardiothoracic Patients: A Pilot Study. Acta Biomed 2021; Vol. 92, N. 1: e2021036.
  34. Tripathi K, Lognathan, S, Trivedi N, Abraham GM: Impact of hepatitis C remission on glycemic control in patient with type 2 diabetes: primary care outpatient experience. J Community Hosp Intern Med Perspect. 2021 May 10;11(3):354-356.
  35. Singh Y, Gogtay M, Gurung S, Trivedi N, Abraham A: Assessment of predictive factors of hepatic steatosis by vibration controlled elastography in patients with hepatitis C. J Community Hosp Intern Med Perspect. 2022; 12 (4): 58-65.